Page last updated: 2024-11-07

tetrahydrocortisone and Carcinoma, Papillary, Follicular

tetrahydrocortisone has been researched along with Carcinoma, Papillary, Follicular in 1 studies

Carcinoma, Papillary, Follicular: A thyroid neoplasm of mixed papillary and follicular arrangement. Its biological behavior and prognosis is the same as that of a papillary adenocarcinoma of the thyroid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1271)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taniyama, M1
Ishikawa, N1
Momotani, N1
Ito, K1
Ban, Y1

Other Studies

1 other study available for tetrahydrocortisone and Carcinoma, Papillary, Follicular

ArticleYear
Toxic multinodular goitre in a patient with generalized resistance to thyroid hormone who harbours the R429Q mutation in the thyroid hormone receptor beta gene.
    Clinical endocrinology, 2001, Volume: 54, Issue:1

    Topics: Amino Acids; Biomarkers; Carcinoma, Papillary, Follicular; Female; Goiter, Nodular; Humans; Middle A

2001